Clinical Trials Browser

Withdrawn × Colorectal Neoplasms × Pemetrexed × Clear all

NCT03843853 2022-07-25

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms